Budesonide and Formoterol Fumarate Dihydrate NDC 0310-7370

Product information

Brand name (proprietary)

Budesonide and Formoterol Fumarate Dihydrate

Generic name (nonproprietary)

budesonide and formoterol fumarate dihydrate

Active ingredients

Budesonide — 160 ug/1Formoterol fumarate — 4.5 ug/1

Dosage form

Aerosol

Route

Respiratory (Inhalation)

Labeler

AstraZeneca Pharmaceuticals LP

Product type

Prescription drug

Marketing category

NDA authorized genericApplication NDA 021929

Marketing start

Jan 3, 2020

Listing expires

Dec 31, 2026

Other FDA classes

Adrenergic beta2-Agonists (Mechanism)Corticosteroid Hormone Receptor Agonists (Mechanism)

Identifiers

Product ID 0310-7370_b500fba8-8294-4c20-b51e-2ce674acf1b3SPL ID b500fba8-8294-4c20-b51e-2ce674acf1b3SPL set ID 1d266fe8-52e3-4f85-a037-c5c1afa15e60RxCUI 1246288, 1246304UNII W34SHF8J2K, Q3OKS62Q6X

Pharmacologic class

Corticosteroid; beta2-Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N400310737020 followed by a unit qualifier and the quantity Copy

Package 00310-7370-20. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under NDA 021929

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.